When comparing the baseline DAT uptake with the uptake at the third year followup in PD patients, the uptake in the putamen was also significantly lower compared to baseline, P < 0.01, as well as the DAT uptake in striate, P < 0.05. Here, SLC6A3 is linked to Parkinson disease.